Global Chorionic Gonadotrophin Market Growth 2023-2029

March 2023 | 114 pages | ID: G152D8F8C3A3EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Human chorionic gonadotropin (HCG), a polypeptide hormone produced by the human placenta. Endogenously produced HCG interacts with the LHCG receptor of the ovary and promotes the maintenance of the corpus luteum during the beginning of pregnancy. This allows the corpus luteum to continuously secrete the hormone progesterone during the first trimester, which is required for maintenance of the uterus and prevents menstruation. In males, HCG also stimulates the production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of the testis to produce androgens.

LPI (LP Information)' newest research report, the “Chorionic Gonadotrophin Industry Forecast” looks at past sales and reviews total world Chorionic Gonadotrophin sales in 2022, providing a comprehensive analysis by region and market sector of projected Chorionic Gonadotrophin sales for 2023 through 2029. With Chorionic Gonadotrophin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chorionic Gonadotrophin industry.

This Insight Report provides a comprehensive analysis of the global Chorionic Gonadotrophin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chorionic Gonadotrophin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Chorionic Gonadotrophin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chorionic Gonadotrophin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chorionic Gonadotrophin.

The global Chorionic Gonadotrophin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Chorionic Gonadotrophin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Chorionic Gonadotrophin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Chorionic Gonadotrophin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Chorionic Gonadotrophin players cover Merck Serono, Bristol Myers Squibb, Ferring, Fresenius Kabi, Sun Pharmaceutical, Besins Healthcare Benelux, Jean-Marie, Organon and Hubei Dongxin Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Chorionic Gonadotrophin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • 500U
  • 1000U
  • 2000U
  • 3000U
  • 5000U
Segmentation by application
  • Undescended Testicles In Adolescence
  • Male Infertility
  • Female Anovulatory Infertility
  • In Vitro Fertilization
  • Abortion
  • Functional Uterine Hemorrhage
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck Serono
  • Bristol Myers Squibb
  • Ferring
  • Fresenius Kabi
  • Sun Pharmaceutical
  • Besins Healthcare Benelux
  • Jean-Marie
  • Organon
  • Hubei Dongxin Pharmaceutical
  • Changchun Jinsai Pharmaceutical
  • Ningbo Renjian Pharmaceutical Group
  • Yantai Dongcheng North Pharmaceutical
  • Maanshan Fengyuan Pharmaceutical
  • Sinopharm
  • Livzon Pharmaceutical Group
  • Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Key Questions Addressed in this Report

What is the 10-year outlook for the global Chorionic Gonadotrophin market?

What factors are driving Chorionic Gonadotrophin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Chorionic Gonadotrophin market opportunities vary by end market size?

How does Chorionic Gonadotrophin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Chorionic Gonadotrophin Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Chorionic Gonadotrophin by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Chorionic Gonadotrophin by Country/Region, 2018, 2022 & 2029
2.2 Chorionic Gonadotrophin Segment by Type
  2.2.1 500U
  2.2.2 1000U
  2.2.3 2000U
  2.2.4 3000U
  2.2.5 5000U
2.3 Chorionic Gonadotrophin Sales by Type
  2.3.1 Global Chorionic Gonadotrophin Sales Market Share by Type (2018-2023)
  2.3.2 Global Chorionic Gonadotrophin Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Chorionic Gonadotrophin Sale Price by Type (2018-2023)
2.4 Chorionic Gonadotrophin Segment by Application
  2.4.1 Undescended Testicles In Adolescence
  2.4.2 Male Infertility
  2.4.3 Female Anovulatory Infertility
  2.4.4 In Vitro Fertilization
  2.4.5 Abortion
  2.4.6 Functional Uterine Hemorrhage
  2.4.7 Other
2.5 Chorionic Gonadotrophin Sales by Application
  2.5.1 Global Chorionic Gonadotrophin Sale Market Share by Application (2018-2023)
  2.5.2 Global Chorionic Gonadotrophin Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Chorionic Gonadotrophin Sale Price by Application (2018-2023)

3 GLOBAL CHORIONIC GONADOTROPHIN BY COMPANY

3.1 Global Chorionic Gonadotrophin Breakdown Data by Company
  3.1.1 Global Chorionic Gonadotrophin Annual Sales by Company (2018-2023)
  3.1.2 Global Chorionic Gonadotrophin Sales Market Share by Company (2018-2023)
3.2 Global Chorionic Gonadotrophin Annual Revenue by Company (2018-2023)
  3.2.1 Global Chorionic Gonadotrophin Revenue by Company (2018-2023)
  3.2.2 Global Chorionic Gonadotrophin Revenue Market Share by Company (2018-2023)
3.3 Global Chorionic Gonadotrophin Sale Price by Company
3.4 Key Manufacturers Chorionic Gonadotrophin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Chorionic Gonadotrophin Product Location Distribution
  3.4.2 Players Chorionic Gonadotrophin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR CHORIONIC GONADOTROPHIN BY GEOGRAPHIC REGION

4.1 World Historic Chorionic Gonadotrophin Market Size by Geographic Region (2018-2023)
  4.1.1 Global Chorionic Gonadotrophin Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Chorionic Gonadotrophin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Chorionic Gonadotrophin Market Size by Country/Region (2018-2023)
  4.2.1 Global Chorionic Gonadotrophin Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Chorionic Gonadotrophin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Chorionic Gonadotrophin Sales Growth
4.4 APAC Chorionic Gonadotrophin Sales Growth
4.5 Europe Chorionic Gonadotrophin Sales Growth
4.6 Middle East & Africa Chorionic Gonadotrophin Sales Growth

5 AMERICAS

5.1 Americas Chorionic Gonadotrophin Sales by Country
  5.1.1 Americas Chorionic Gonadotrophin Sales by Country (2018-2023)
  5.1.2 Americas Chorionic Gonadotrophin Revenue by Country (2018-2023)
5.2 Americas Chorionic Gonadotrophin Sales by Type
5.3 Americas Chorionic Gonadotrophin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Chorionic Gonadotrophin Sales by Region
  6.1.1 APAC Chorionic Gonadotrophin Sales by Region (2018-2023)
  6.1.2 APAC Chorionic Gonadotrophin Revenue by Region (2018-2023)
6.2 APAC Chorionic Gonadotrophin Sales by Type
6.3 APAC Chorionic Gonadotrophin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Chorionic Gonadotrophin by Country
  7.1.1 Europe Chorionic Gonadotrophin Sales by Country (2018-2023)
  7.1.2 Europe Chorionic Gonadotrophin Revenue by Country (2018-2023)
7.2 Europe Chorionic Gonadotrophin Sales by Type
7.3 Europe Chorionic Gonadotrophin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Chorionic Gonadotrophin by Country
  8.1.1 Middle East & Africa Chorionic Gonadotrophin Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Chorionic Gonadotrophin Revenue by Country (2018-2023)
8.2 Middle East & Africa Chorionic Gonadotrophin Sales by Type
8.3 Middle East & Africa Chorionic Gonadotrophin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chorionic Gonadotrophin
10.3 Manufacturing Process Analysis of Chorionic Gonadotrophin
10.4 Industry Chain Structure of Chorionic Gonadotrophin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Chorionic Gonadotrophin Distributors
11.3 Chorionic Gonadotrophin Customer

12 WORLD FORECAST REVIEW FOR CHORIONIC GONADOTROPHIN BY GEOGRAPHIC REGION

12.1 Global Chorionic Gonadotrophin Market Size Forecast by Region
  12.1.1 Global Chorionic Gonadotrophin Forecast by Region (2024-2029)
  12.1.2 Global Chorionic Gonadotrophin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chorionic Gonadotrophin Forecast by Type
12.7 Global Chorionic Gonadotrophin Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Merck Serono
  13.1.1 Merck Serono Company Information
  13.1.2 Merck Serono Chorionic Gonadotrophin Product Portfolios and Specifications
  13.1.3 Merck Serono Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Merck Serono Main Business Overview
  13.1.5 Merck Serono Latest Developments
13.2 Bristol Myers Squibb
  13.2.1 Bristol Myers Squibb Company Information
  13.2.2 Bristol Myers Squibb Chorionic Gonadotrophin Product Portfolios and Specifications
  13.2.3 Bristol Myers Squibb Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Bristol Myers Squibb Main Business Overview
  13.2.5 Bristol Myers Squibb Latest Developments
13.3 Ferring
  13.3.1 Ferring Company Information
  13.3.2 Ferring Chorionic Gonadotrophin Product Portfolios and Specifications
  13.3.3 Ferring Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Ferring Main Business Overview
  13.3.5 Ferring Latest Developments
13.4 Fresenius Kabi
  13.4.1 Fresenius Kabi Company Information
  13.4.2 Fresenius Kabi Chorionic Gonadotrophin Product Portfolios and Specifications
  13.4.3 Fresenius Kabi Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Fresenius Kabi Main Business Overview
  13.4.5 Fresenius Kabi Latest Developments
13.5 Sun Pharmaceutical
  13.5.1 Sun Pharmaceutical Company Information
  13.5.2 Sun Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
  13.5.3 Sun Pharmaceutical Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Sun Pharmaceutical Main Business Overview
  13.5.5 Sun Pharmaceutical Latest Developments
13.6 Besins Healthcare Benelux
  13.6.1 Besins Healthcare Benelux Company Information
  13.6.2 Besins Healthcare Benelux Chorionic Gonadotrophin Product Portfolios and Specifications
  13.6.3 Besins Healthcare Benelux Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Besins Healthcare Benelux Main Business Overview
  13.6.5 Besins Healthcare Benelux Latest Developments
13.7 Jean-Marie
  13.7.1 Jean-Marie Company Information
  13.7.2 Jean-Marie Chorionic Gonadotrophin Product Portfolios and Specifications
  13.7.3 Jean-Marie Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Jean-Marie Main Business Overview
  13.7.5 Jean-Marie Latest Developments
13.8 Organon
  13.8.1 Organon Company Information
  13.8.2 Organon Chorionic Gonadotrophin Product Portfolios and Specifications
  13.8.3 Organon Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Organon Main Business Overview
  13.8.5 Organon Latest Developments
13.9 Hubei Dongxin Pharmaceutical
  13.9.1 Hubei Dongxin Pharmaceutical Company Information
  13.9.2 Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
  13.9.3 Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Hubei Dongxin Pharmaceutical Main Business Overview
  13.9.5 Hubei Dongxin Pharmaceutical Latest Developments
13.10 Changchun Jinsai Pharmaceutical
  13.10.1 Changchun Jinsai Pharmaceutical Company Information
  13.10.2 Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
  13.10.3 Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Changchun Jinsai Pharmaceutical Main Business Overview
  13.10.5 Changchun Jinsai Pharmaceutical Latest Developments
13.11 Ningbo Renjian Pharmaceutical Group
  13.11.1 Ningbo Renjian Pharmaceutical Group Company Information
  13.11.2 Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Product Portfolios and Specifications
  13.11.3 Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Ningbo Renjian Pharmaceutical Group Main Business Overview
  13.11.5 Ningbo Renjian Pharmaceutical Group Latest Developments
13.12 Yantai Dongcheng North Pharmaceutical
  13.12.1 Yantai Dongcheng North Pharmaceutical Company Information
  13.12.2 Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
  13.12.3 Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Yantai Dongcheng North Pharmaceutical Main Business Overview
  13.12.5 Yantai Dongcheng North Pharmaceutical Latest Developments
13.13 Maanshan Fengyuan Pharmaceutical
  13.13.1 Maanshan Fengyuan Pharmaceutical Company Information
  13.13.2 Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
  13.13.3 Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Maanshan Fengyuan Pharmaceutical Main Business Overview
  13.13.5 Maanshan Fengyuan Pharmaceutical Latest Developments
13.14 Sinopharm
  13.14.1 Sinopharm Company Information
  13.14.2 Sinopharm Chorionic Gonadotrophin Product Portfolios and Specifications
  13.14.3 Sinopharm Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Sinopharm Main Business Overview
  13.14.5 Sinopharm Latest Developments
13.15 Livzon Pharmaceutical Group
  13.15.1 Livzon Pharmaceutical Group Company Information
  13.15.2 Livzon Pharmaceutical Group Chorionic Gonadotrophin Product Portfolios and Specifications
  13.15.3 Livzon Pharmaceutical Group Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Livzon Pharmaceutical Group Main Business Overview
  13.15.5 Livzon Pharmaceutical Group Latest Developments
13.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
  13.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Information
  13.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Product Portfolios and Specifications
  13.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Main Business Overview
  13.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Chorionic Gonadotrophin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Chorionic Gonadotrophin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 500U
Table 4. Major Players of 1000U
Table 5. Major Players of 2000U
Table 6. Major Players of 3000U
Table 7. Major Players of 5000U
Table 8. Global Chorionic Gonadotrophin Sales by Type (2018-2023) & (KG)
Table 9. Global Chorionic Gonadotrophin Sales Market Share by Type (2018-2023)
Table 10. Global Chorionic Gonadotrophin Revenue by Type (2018-2023) & ($ million)
Table 11. Global Chorionic Gonadotrophin Revenue Market Share by Type (2018-2023)
Table 12. Global Chorionic Gonadotrophin Sale Price by Type (2018-2023) & (US$/G)
Table 13. Global Chorionic Gonadotrophin Sales by Application (2018-2023) & (KG)
Table 14. Global Chorionic Gonadotrophin Sales Market Share by Application (2018-2023)
Table 15. Global Chorionic Gonadotrophin Revenue by Application (2018-2023)
Table 16. Global Chorionic Gonadotrophin Revenue Market Share by Application (2018-2023)
Table 17. Global Chorionic Gonadotrophin Sale Price by Application (2018-2023) & (US$/G)
Table 18. Global Chorionic Gonadotrophin Sales by Company (2018-2023) & (KG)
Table 19. Global Chorionic Gonadotrophin Sales Market Share by Company (2018-2023)
Table 20. Global Chorionic Gonadotrophin Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Chorionic Gonadotrophin Revenue Market Share by Company (2018-2023)
Table 22. Global Chorionic Gonadotrophin Sale Price by Company (2018-2023) & (US$/G)
Table 23. Key Manufacturers Chorionic Gonadotrophin Producing Area Distribution and Sales Area
Table 24. Players Chorionic Gonadotrophin Products Offered
Table 25. Chorionic Gonadotrophin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Chorionic Gonadotrophin Sales by Geographic Region (2018-2023) & (KG)
Table 29. Global Chorionic Gonadotrophin Sales Market Share Geographic Region (2018-2023)
Table 30. Global Chorionic Gonadotrophin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Chorionic Gonadotrophin Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Chorionic Gonadotrophin Sales by Country/Region (2018-2023) & (KG)
Table 33. Global Chorionic Gonadotrophin Sales Market Share by Country/Region (2018-2023)
Table 34. Global Chorionic Gonadotrophin Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Chorionic Gonadotrophin Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Chorionic Gonadotrophin Sales by Country (2018-2023) & (KG)
Table 37. Americas Chorionic Gonadotrophin Sales Market Share by Country (2018-2023)
Table 38. Americas Chorionic Gonadotrophin Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Chorionic Gonadotrophin Revenue Market Share by Country (2018-2023)
Table 40. Americas Chorionic Gonadotrophin Sales by Type (2018-2023) & (KG)
Table 41. Americas Chorionic Gonadotrophin Sales by Application (2018-2023) & (KG)
Table 42. APAC Chorionic Gonadotrophin Sales by Region (2018-2023) & (KG)
Table 43. APAC Chorionic Gonadotrophin Sales Market Share by Region (2018-2023)
Table 44. APAC Chorionic Gonadotrophin Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Chorionic Gonadotrophin Revenue Market Share by Region (2018-2023)
Table 46. APAC Chorionic Gonadotrophin Sales by Type (2018-2023) & (KG)
Table 47. APAC Chorionic Gonadotrophin Sales by Application (2018-2023) & (KG)
Table 48. Europe Chorionic Gonadotrophin Sales by Country (2018-2023) & (KG)
Table 49. Europe Chorionic Gonadotrophin Sales Market Share by Country (2018-2023)
Table 50. Europe Chorionic Gonadotrophin Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Chorionic Gonadotrophin Revenue Market Share by Country (2018-2023)
Table 52. Europe Chorionic Gonadotrophin Sales by Type (2018-2023) & (KG)
Table 53. Europe Chorionic Gonadotrophin Sales by Application (2018-2023) & (KG)
Table 54. Middle East & Africa Chorionic Gonadotrophin Sales by Country (2018-2023) & (KG)
Table 55. Middle East & Africa Chorionic Gonadotrophin Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Chorionic Gonadotrophin Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Chorionic Gonadotrophin Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Chorionic Gonadotrophin Sales by Type (2018-2023) & (KG)
Table 59. Middle East & Africa Chorionic Gonadotrophin Sales by Application (2018-2023) & (KG)
Table 60. Key Market Drivers & Growth Opportunities of Chorionic Gonadotrophin
Table 61. Key Market Challenges & Risks of Chorionic Gonadotrophin
Table 62. Key Industry Trends of Chorionic Gonadotrophin
Table 63. Chorionic Gonadotrophin Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Chorionic Gonadotrophin Distributors List
Table 66. Chorionic Gonadotrophin Customer List
Table 67. Global Chorionic Gonadotrophin Sales Forecast by Region (2024-2029) & (KG)
Table 68. Global Chorionic Gonadotrophin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Chorionic Gonadotrophin Sales Forecast by Country (2024-2029) & (KG)
Table 70. Americas Chorionic Gonadotrophin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Chorionic Gonadotrophin Sales Forecast by Region (2024-2029) & (KG)
Table 72. APAC Chorionic Gonadotrophin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Chorionic Gonadotrophin Sales Forecast by Country (2024-2029) & (KG)
Table 74. Europe Chorionic Gonadotrophin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Chorionic Gonadotrophin Sales Forecast by Country (2024-2029) & (KG)
Table 76. Middle East & Africa Chorionic Gonadotrophin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Chorionic Gonadotrophin Sales Forecast by Type (2024-2029) & (KG)
Table 78. Global Chorionic Gonadotrophin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Chorionic Gonadotrophin Sales Forecast by Application (2024-2029) & (KG)
Table 80. Global Chorionic Gonadotrophin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Merck Serono Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Serono Chorionic Gonadotrophin Product Portfolios and Specifications
Table 83. Merck Serono Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 84. Merck Serono Main Business
Table 85. Merck Serono Latest Developments
Table 86. Bristol Myers Squibb Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 87. Bristol Myers Squibb Chorionic Gonadotrophin Product Portfolios and Specifications
Table 88. Bristol Myers Squibb Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 89. Bristol Myers Squibb Main Business
Table 90. Bristol Myers Squibb Latest Developments
Table 91. Ferring Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 92. Ferring Chorionic Gonadotrophin Product Portfolios and Specifications
Table 93. Ferring Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 94. Ferring Main Business
Table 95. Ferring Latest Developments
Table 96. Fresenius Kabi Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 97. Fresenius Kabi Chorionic Gonadotrophin Product Portfolios and Specifications
Table 98. Fresenius Kabi Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 99. Fresenius Kabi Main Business
Table 100. Fresenius Kabi Latest Developments
Table 101. Sun Pharmaceutical Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 102. Sun Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
Table 103. Sun Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 104. Sun Pharmaceutical Main Business
Table 105. Sun Pharmaceutical Latest Developments
Table 106. Besins Healthcare Benelux Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 107. Besins Healthcare Benelux Chorionic Gonadotrophin Product Portfolios and Specifications
Table 108. Besins Healthcare Benelux Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 109. Besins Healthcare Benelux Main Business
Table 110. Besins Healthcare Benelux Latest Developments
Table 111. Jean-Marie Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 112. Jean-Marie Chorionic Gonadotrophin Product Portfolios and Specifications
Table 113. Jean-Marie Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 114. Jean-Marie Main Business
Table 115. Jean-Marie Latest Developments
Table 116. Organon Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 117. Organon Chorionic Gonadotrophin Product Portfolios and Specifications
Table 118. Organon Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 119. Organon Main Business
Table 120. Organon Latest Developments
Table 121. Hubei Dongxin Pharmaceutical Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 122. Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
Table 123. Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 124. Hubei Dongxin Pharmaceutical Main Business
Table 125. Hubei Dongxin Pharmaceutical Latest Developments
Table 126. Changchun Jinsai Pharmaceutical Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 127. Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
Table 128. Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 129. Changchun Jinsai Pharmaceutical Main Business
Table 130. Changchun Jinsai Pharmaceutical Latest Developments
Table 131. Ningbo Renjian Pharmaceutical Group Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 132. Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Product Portfolios and Specifications
Table 133. Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 134. Ningbo Renjian Pharmaceutical Group Main Business
Table 135. Ningbo Renjian Pharmaceutical Group Latest Developments
Table 136. Yantai Dongcheng North Pharmaceutical Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 137. Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
Table 138. Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 139. Yantai Dongcheng North Pharmaceutical Main Business
Table 140. Yantai Dongcheng North Pharmaceutical Latest Developments
Table 141. Maanshan Fengyuan Pharmaceutical Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 142. Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Product Portfolios and Specifications
Table 143. Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 144. Maanshan Fengyuan Pharmaceutical Main Business
Table 145. Maanshan Fengyuan Pharmaceutical Latest Developments
Table 146. Sinopharm Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 147. Sinopharm Chorionic Gonadotrophin Product Portfolios and Specifications
Table 148. Sinopharm Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 149. Sinopharm Main Business
Table 150. Sinopharm Latest Developments
Table 151. Livzon Pharmaceutical Group Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 152. Livzon Pharmaceutical Group Chorionic Gonadotrophin Product Portfolios and Specifications
Table 153. Livzon Pharmaceutical Group Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 154. Livzon Pharmaceutical Group Main Business
Table 155. Livzon Pharmaceutical Group Latest Developments
Table 156. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Basic Information, Chorionic Gonadotrophin Manufacturing Base, Sales Area and Its Competitors
Table 157. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Product Portfolios and Specifications
Table 158. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 159. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Main Business
Table 160. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Latest Developments

LIST OF FIGURES

Figure 1. Picture of Chorionic Gonadotrophin
Figure 2. Chorionic Gonadotrophin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chorionic Gonadotrophin Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Chorionic Gonadotrophin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Chorionic Gonadotrophin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 500U
Figure 10. Product Picture of 1000U
Figure 11. Product Picture of 2000U
Figure 12. Product Picture of 3000U
Figure 13. Product Picture of 5000U
Figure 14. Global Chorionic Gonadotrophin Sales Market Share by Type in 2022
Figure 15. Global Chorionic Gonadotrophin Revenue Market Share by Type (2018-2023)
Figure 16. Chorionic Gonadotrophin Consumed in Undescended Testicles In Adolescence
Figure 17. Global Chorionic Gonadotrophin Market: Undescended Testicles In Adolescence (2018-2023) & (KG)
Figure 18. Chorionic Gonadotrophin Consumed in Male Infertility
Figure 19. Global Chorionic Gonadotrophin Market: Male Infertility (2018-2023) & (KG)
Figure 20. Chorionic Gonadotrophin Consumed in Female Anovulatory Infertility
Figure 21. Global Chorionic Gonadotrophin Market: Female Anovulatory Infertility (2018-2023) & (KG)
Figure 22. Chorionic Gonadotrophin Consumed in In Vitro Fertilization
Figure 23. Global Chorionic Gonadotrophin Market: In Vitro Fertilization (2018-2023) & (KG)
Figure 24. Chorionic Gonadotrophin Consumed in Abortion
Figure 25. Global Chorionic Gonadotrophin Market: Abortion (2018-2023) & (KG)
Figure 26. Chorionic Gonadotrophin Consumed in Functional Uterine Hemorrhage
Figure 27. Global Chorionic Gonadotrophin Market: Functional Uterine Hemorrhage (2018-2023) & (KG)
Figure 28. Chorionic Gonadotrophin Consumed in Other
Figure 29. Global Chorionic Gonadotrophin Market: Other (2018-2023) & (KG)
Figure 30. Global Chorionic Gonadotrophin Sales Market Share by Application (2022)
Figure 31. Global Chorionic Gonadotrophin Revenue Market Share by Application in 2022
Figure 32. Chorionic Gonadotrophin Sales Market by Company in 2022 (KG)
Figure 33. Global Chorionic Gonadotrophin Sales Market Share by Company in 2022
Figure 34. Chorionic Gonadotrophin Revenue Market by Company in 2022 ($ Million)
Figure 35. Global Chorionic Gonadotrophin Revenue Market Share by Company in 2022
Figure 36. Global Chorionic Gonadotrophin Sales Market Share by Geographic Region (2018-2023)
Figure 37. Global Chorionic Gonadotrophin Revenue Market Share by Geographic Region in 2022
Figure 38. Americas Chorionic Gonadotrophin Sales 2018-2023 (KG)
Figure 39. Americas Chorionic Gonadotrophin Revenue 2018-2023 ($ Millions)
Figure 40. APAC Chorionic Gonadotrophin Sales 2018-2023 (KG)
Figure 41. APAC Chorionic Gonadotrophin Revenue 2018-2023 ($ Millions)
Figure 42. Europe Chorionic Gonadotrophin Sales 2018-2023 (KG)
Figure 43. Europe Chorionic Gonadotrophin Revenue 2018-2023 ($ Millions)
Figure 44. Middle East & Africa Chorionic Gonadotrophin Sales 2018-2023 (KG)
Figure 45. Middle East & Africa Chorionic Gonadotrophin Revenue 2018-2023 ($ Millions)
Figure 46. Americas Chorionic Gonadotrophin Sales Market Share by Country in 2022
Figure 47. Americas Chorionic Gonadotrophin Revenue Market Share by Country in 2022
Figure 48. Americas Chorionic Gonadotrophin Sales Market Share by Type (2018-2023)
Figure 49. Americas Chorionic Gonadotrophin Sales Market Share by Application (2018-2023)
Figure 50. United States Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 51. Canada Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Mexico Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Brazil Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 54. APAC Chorionic Gonadotrophin Sales Market Share by Region in 2022
Figure 55. APAC Chorionic Gonadotrophin Revenue Market Share by Regions in 2022
Figure 56. APAC Chorionic Gonadotrophin Sales Market Share by Type (2018-2023)
Figure 57. APAC Chorionic Gonadotrophin Sales Market Share by Application (2018-2023)
Figure 58. China Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Japan Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 60. South Korea Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Southeast Asia Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 62. India Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Australia Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 64. China Taiwan Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 65. Europe Chorionic Gonadotrophin Sales Market Share by Country in 2022
Figure 66. Europe Chorionic Gonadotrophin Revenue Market Share by Country in 2022
Figure 67. Europe Chorionic Gonadotrophin Sales Market Share by Type (2018-2023)
Figure 68. Europe Chorionic Gonadotrophin Sales Market Share by Application (2018-2023)
Figure 69. Germany Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 70. France Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 71. UK Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Italy Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 73. Russia Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 74. Middle East & Africa Chorionic Gonadotrophin Sales Market Share by Country in 2022
Figure 75. Middle East & Africa Chorionic Gonadotrophin Revenue Market Share by Country in 2022
Figure 76. Middle East & Africa Chorionic Gonadotrophin Sales Market Share by Type (2018-2023)
Figure 77. Middle East & Africa Chorionic Gonadotrophin Sales Market Share by Application (2018-2023)
Figure 78. Egypt Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 79. South Africa Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 80. Israel Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 81. Turkey Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 82. GCC Country Chorionic Gonadotrophin Revenue Growth 2018-2023 ($ Millions)
Figure 83. Manufacturing Cost Structure Analysis of Chorionic Gonadotrophin in 2022
Figure 84. Manufacturing Process Analysis of Chorionic Gonadotrophin
Figure 85. Industry Chain Structure of Chorionic Gonadotrophin
Figure 86. Channels of Distribution
Figure 87. Global Chorionic Gonadotrophin Sales Market Forecast by Region (2024-2029)
Figure 88. Global Chorionic Gonadotrophin Revenue Market Share Forecast by Region (2024-2029)
Figure 89. Global Chorionic Gonadotrophin Sales Market Share Forecast by Type (2024-2029)
Figure 90. Global Chorionic Gonadotrophin Revenue Market Share Forecast by Type (2024-2029)
Figure 91. Global Chorionic Gonadotrophin Sales Market Share Forecast by Application (2024-2029)
Figure 92. Global Chorionic Gonadotrophin Revenue Market Share Forecast by Application (2024-2029)


More Publications